[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80632]], camposKey:2193-8245 2023-12-01 In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I¿II Clinical Trial32513262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81074]], camposKey:2405-8440 2023-06-01 International survey on dry eye diagnosis by experts00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81075]], camposKey:2673-3080 2023-01-01 Mercury intoxication and ophthalmic involvement: An update review00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75236]], camposKey:1120-6721 2023-01-01 Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease188195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76080]], camposKey:2168-6165 2022-12-15 Toward Universal Eye Health Coverage - Key Outcomes of the World Health Organization Package of Eye Care Interventions: A Systematic Review12291238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72870]], camposKey:2045-2322 2022-10-06 Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75390]], camposKey:2076-3417 2022-10-01 New Method for the Automated Assessment of Corneal Nerve Tortuosity Using Confocal Microscopy Imaging00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75140]], camposKey:1542-0124 2022-10-01 Phenotypic characterization of patients developing chronic dry eye and pain after refractive surgery: A cross-sectional study6374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75546]], camposKey:2073-4409 2022-08-01 Corneal Regeneration Using Adipose-Derived Mesenchymal Stem Cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72871]], camposKey:0014-4835 2022-06-01 Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88192]], camposKey:0146-0404 2022-01-01 Bone marrow- and adipose tissue-derived mesenchymal stem cells partially restore corneal and limbal epithelial phenotype in a rabbit model of limbal stem cell deficiency00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76832]], camposKey:1999-4923 2021-01-01 Advanced therapy medicinal products for the eye: definitions and regulatory framework3470, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63933]], camposKey:0213-3911 2021-01-01 Epithelial component and intraepithelial lymphocytes of conjunctiva-associated lymphoid tissue in healthy children12731283, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76833]], camposKey:1999-4923 2021-01-01 Goals and challenges of stem cell-based therapy for corneal blindness due to limbal deficiency14830, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76831]], camposKey:1757-6512 2021-01-01 Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: state of the art00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59335]], camposKey:1542-0124 2020-10-01 Inflammatory status predicts contact lens discomfort under adverse environmental conditions829840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52801]], camposKey:0014-4835 2020-01-01 Clinical and tear cytokine profiles after advanced surface ablation refractive surgery: A six-month follow-up00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52911]], camposKey:1542-2321 2020-01-01 Development of a Questionnaire for Detecting Changes in Dry Eye Disease-Related Symptoms00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66405]], camposKey:1064-3745 2020-01-01 Optimization of Human Limbal Stem Cell Culture by Replating a Single Limbal Explant3949, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66404]], camposKey:1064-3745 2020-01-01 Optimization of Human Limbal Stem Cell Culture by Replating a Single Limbal Explant (Jun, 10.1007/978-1-0716-0599-8_4, 2020)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52802]], camposKey:0929-8673 2020-01-01 Tear inflammatory molecules in contact lens wearers: A literature review523548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41610]], camposKey:1755-375X 2019-03-01 Role of corneal nerves in ocular surface homeostasis and disease137145, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41609]], camposKey:1931-5244 2019-01-01 A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency1840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52915]], camposKey:1699-1036 2019-01-01 Eficacia del trasplante de células madre mesenquimales de médula ósea y de tejido adiposo en un modelo de deficiencia de células madre limbares desarrollado en conejo: estudio comparativo172172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52916]], camposKey:1699-1036 2019-01-01 Eficacia del trasplante de células madre mesenquimales de médula ósea y de tejido adiposo en un modelo de deficiencia de células madre limbares desarrollado en conejo: estudio comparativo3639, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56652]], camposKey:0146-0404 2019-01-01 Ocular Surface Pathology in Patients Suffering from Acute Intoxication with Occupational Mercury00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41608]], camposKey:0927-7765 2019-01-01 Poly-L/DL-lactic acid films functionalized with collagen IV as carrier substrata for corneal epithelial stem cells121129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41511]], camposKey:1542-0124 2019-01-01 Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes502515, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42955]], camposKey:0927-3948 2019-01-01 Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease10231032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41611]], camposKey:0271-3683 2018-04-03 Controlled Adverse Environment Chambers in Dry Eye Research445450, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11553]], camposKey:0271-3683 2018-01-01 Are Contact Lens Discomfort or Soft Contact Lens Material Properties Associated with Alterations in the Corneal Sub-Basal Nerve Plexus?487492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52914]], camposKey:1699-1036 2018-01-01 Estudio de la tolerabilidad y la eficacia del trasplante de células madre mesenquimales de médula ósea en un modelo de síndrome de insuficiencia límbica189190, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37802]], camposKey:1542-0124 2018-01-01 Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial368376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3536]], camposKey:1542-0124 2018-01-01 Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears8492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3531]], camposKey:0271-3683 2017-07-03 Clinical Features and Prognostic Factors in Presumed Ocular Tuberculosis10291034, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47865]], camposKey:0146-0404 2017-01-01 A Randomized Controlled Trial of Cultivated Limbal Epithelial Cells Compared to Mesenchymal Stem Cells for the Treatment of Corneal Failure due to Limbal Stem Cell Deficiency00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41612]], camposKey:1755-375X 2017-01-01 Cytokine and chemokine tear levels in patients with uveitis405414, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3534]], camposKey:0020-8167 2017-01-01 Effects of the external environment on dry eye disease2340, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52913]], camposKey:1699-1036 2017-01-01 Inflamación de la superficie ocular en un modelo parcial y total de síndrome de insuficiencia límbica204204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3535]], camposKey:0275-5408 2017-01-01 Ocular response to environmental variations in contact lens wearers6070, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3529]], camposKey:0146-0404 2017-01-01 Prehematopoietic stem cell transplantation tear cytokines as potential susceptibility biomarkers for ocular chronic graft-versus-host disease48364846, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3533]], camposKey:0161-6420 2017-01-01 Reply02, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3532]], camposKey:0271-3683 2017-01-01 Successful Consecutive Expansion of Limbal Explants Using a Biosafe Culture Medium under Feeder Layer-Free Conditions685695, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3528]], camposKey:1066-5099 2017-01-01 Therapeutic Effect of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Experimental Corneal Failure Due to Limbal Stem Cell Niche Damage21602174, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3543]], camposKey:0146-0404 2016-01-01 Biomarkers in ocular chronic graft versus host disease: Tear cytokine- and chemokine-based predictive model746758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3541]], camposKey:0002-9394 2016-01-01 Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients under Desiccating Stress00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3540]], camposKey:0014-4835 2016-01-01 Comparison of functional limbal epithelial stem cell isolation methods8394, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3537]], camposKey:1040-5488 2016-01-01 Corneal sensitivity and inflammatory biomarkers in contact lens discomfort892900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3538]], camposKey:0277-3740 2016-01-01 Effect of environmental conditions on the concentration of tear inflammatory mediators during contact lens wear11921198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3539]], camposKey:1040-5488 2016-01-01 Lack of agreement among electrical impedance and freezing-point osmometers482487, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39503]], camposKey:0146-0404 2016-01-01 Tear fluid proteome reveals inflammation and immune response proteins as potential predictive biomarkers of the effects of desiccating stress and dry eye treatments00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3542]], camposKey:0161-6420 2016-01-01 Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial141153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=682]], camposKey:0213-3911 2015-02-01 In vivo confocal microscopy assessment of the corneoscleral limbal stem cell niche before and after biopsy for cultivated limbal epithelial transplantation to restore corneal epithelium183192, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8939]], camposKey:1755-375X 2015-01-01 Environmental factors in ocular surface disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3547]], camposKey:0146-0404 2015-01-01 Gene expression-based predictive models of graft versus host disease-associated dry eye45704581, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49171]], camposKey:0146-0404 2015-01-01 Improvement of limbal and corneal phenotype after transplantation of human adipose tissue-derived mesenchymal stem cells in an in vivo model of ocular surface failure00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3545]], camposKey:1040-5488 2015-01-01 Influence of climate on clinical diagnostic dry eye tests: Pilot study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3544]], camposKey:0146-0404 2015-01-01 Quercetin and resveratrol decrease the inflammatory and oxidative responses in human ocular surface epithelial cells27092719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10418]], camposKey:0146-0404 2015-01-01 Soluble hyaluronan receptor CD44 levels secreted by human conjunctival cells change in inflammatory conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3546]], camposKey:2314-6133 2015-01-01 Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=768]], camposKey:0271-3683 2014-01-01 Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance673679, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49168]], camposKey:0146-0404 2014-01-01 Biosafe culture medium optimization for in vitro expansion of limbal epithelial stem cells for clinical transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=680]], camposKey:0721-832X 2014-01-01 CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation12891295, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=788]], camposKey:0002-9394 2014-01-01 Dry Eye Exacerbation in Patients Exposed to Desiccating Stress under Controlled Environmental Conditions788798, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=759]], camposKey:1552-4973 2014-01-01 Influence of environmental factors in the in vitro dehydration of hydrogel and silicone hydrogel contact lenses764771, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=751]], camposKey:0014-4835 2014-01-01 Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects4349, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49169]], camposKey:0146-0404 2014-01-01 Safety and preliminary efficacy of human adipose tissue mesenchymal stem cells (hATMSC) to restore the ocular surface in an in vivo experimental model of limbal stem cell deficiency (LSCD)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=728]], camposKey:1542-0124 2013-10-01 Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting246258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=646]], camposKey:0146-0404 2013-07-01 Mitochondrial Permeability Transition Pore in Inflammatory Apoptosis of Human Conjunctival Epithelial Cells and T Cells: Effect of Cyclosporin A47174733, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=663]], camposKey:0969-7128 2013-01-01 A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model467477, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=796]], camposKey:0957-4530 2013-01-01 Chitosan-gelatin biopolymers as carrier substrata for limbal epithelial stem cells28192829, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=755]], camposKey:0271-3683 2013-01-01 Consecutive Expansion of Limbal Epithelial Stem Cells from a Single Limbal Biopsy537549, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=729]], camposKey:0014-4835 2013-01-01 Effect of TGF-beta on ocular surface epithelial cells88100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=694]], camposKey:0732-8893 2013-01-01 Fatal disseminated Scedosporium prolificans infection initiated by ophthalmic involvement in a patient with acute myeloblastic leukemia375378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=779]], camposKey:0271-3683 2013-01-01 In Vitro Simulation of Corneal Epithelium Microenvironment Induces a Corneal Epithelial-like Cell Phenotype from Human Adipose Tissue Mesenchymal Stem Cells933944, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=792]], camposKey:0146-0404 2013-01-01 Influence of a Controlled Environment Simulating an In-Flight Airplane Cabin on Dry Eye Disease20932099, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=642]], camposKey:0277-3740 2013-01-01 Oculopalpebral Borreliosis as an Unusual Manifestation of Lyme Disease8790, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=674]], camposKey:0927-3948 2012-12-01 Distinctive Clinical Features of Idiopathic versus Infectious Serpiginous Choroidopathy448452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=671]], camposKey:0146-0404 2012-04-01 Autoantibodies Contribute to the Immunopathogenesis of Experimental Dry Eye Disease20622075, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=730]], camposKey:0146-0404 2012-01-01 Characterization by Belmonte's Gas Esthesiometer of Mechanical, Chemical, and Thermal Corneal Sensitivity Thresholds in a Normal Population31543160, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=736]], camposKey:0271-3683 2012-01-01 Correlations Among Symptoms, Signs, and Clinical Tests in Evaporative-Type Dry Eye Disease Caused by Meibomian Gland Dysfunction (MGD)855863, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=780]], camposKey:1528-4050 2012-01-01 Molecular and cellular biomarkers in dry eye disease and ocular allergy523533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=695]], camposKey:1933-0219 2012-01-01 Topographical distribution and characterization of epithelial cells and intraepithelial lymphocytes in the human ocular mucosa455467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=789]], camposKey:1353-4505 2011-12-01 What makes hospitalized patients more vulnerable and increases their risk of experiencing an adverse event?705712, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=686]], camposKey:0041-1345 2011-06-01 Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study19341938, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=675]], camposKey:0008-4182 2011-02-01 Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=703]], camposKey:1090-0535 2011-01-01 A comparison of stem cell-related gene expression in the progenitor-rich limbal epithelium and the differentiating central corneal epithelium21022117, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=746]], camposKey:0146-0404 2011-01-01 Activation of MAPK Signaling Pathway and NF-kappa B Activation in Pterygium and Ipsilateral Pterygium-Free Conjunctival Specimens58425852, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=766]], camposKey:1040-5488 2011-01-01 Contact Lens Case Cleaning Procedures Affect Storage Solution pH and Osmolality14141421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=717]], camposKey:0146-0404 2011-01-01 Differential Cell Proliferation, Apoptosis, and Immune Response in Healthy and Evaporative-Type Dry Eye Conjunctival Epithelia48194828, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=757]], camposKey:1090-0535 2011-01-01 Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells279290, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3550]], camposKey:1177-5467 2011-01-01 Intraocular inflammation as the main manifestation of Rickettsia conorii infection14011407, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3551]], camposKey:0365-6691 2011-01-01 Lack of concordance between dry eye syndrome questionnaires and diagnostic tests Falta de concordancia entre los cuestionarios y las pruebas diagnósticas en el síndrome de ojo seco37, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=772]], camposKey:0146-0404 2011-01-01 Ocular Mucin Gene Expression Levels as Biomarkers for the Diagnosis of Dry Eye Syndrome83638369, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29497]], camposKey:0212-4394 2011-01-01 Procedimientos de valoración de la función visual en el síndrome de ojo seco3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=786]], camposKey:0730-2312 2011-01-01 Regulation of Dab2 Expression in Intestinal and Renal Epithelia by Development354361, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46973]], camposKey:1869-5760 2011-01-01 Surgical outcomes of uveitic glaucoma4353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29496]], camposKey:2173-9366 2011-01-01 Técnicas diagnósticas para el síndrome de ojo seco (I)1220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=672]], camposKey:1350-9462 2010-11-01 Applications of nanoparticles in ophthalmology596609, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=635]], camposKey:1933-0219 2010-09-01 Autoimmunity at the ocular surface: pathogenesis and regulation425442, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50860]], camposKey:1560-2133 2010-01-01 Choroidal neovascularisation in punctate inner choroidopathy: therapeutic options.1928, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=742]], camposKey:1755-375X 2010-01-01 Cytokine and chemokine levels in tears from healthy subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=790]], camposKey:0927-3948 2010-01-01 Dry Eye Disease as an Inflammatory Disorder244253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=760]], camposKey:0277-3740 2010-01-01 Ocular Tolerance to a Topical Formulation of Hyaluronic Acid and Chitosan-Based Nanoparticles550558, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=731]], camposKey:1090-0535 2010-01-01 Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease862873, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=683]], camposKey:0014-4835 2009-08-01 Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone238245, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=664]], camposKey:1542-0124 2009-04-01 Immunoregulation on the Ocular Surface: 2nd Cullen Symposium6777, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=661]], camposKey:1090-0535 2009-01-01 Characterization and short-term culture of cells recovered from human conjunctival epithelium by minimally invasive means21852195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=719]], camposKey:1052-2166 2009-01-01 Comparison of Gene Expression Profiles of Conjunctival Cell Lines With Primary Cultured Conjunctival Epithelial Cells and Human Conjunctival Tissue265278, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=784]], camposKey:1040-5488 2009-01-01 Conjunctival Mucin mRNA Expression in Contact Lens Wear10511058, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=310]], camposKey:0271-3683 2009-01-01 Genetically Engineered Elastin-Like Polymer as a Substratum to Culture Cells from the Ocular Surface4856, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=638]], camposKey:0146-0404 2008-12-01 In Vitro Expanded CD4(+)CD25(+)Foxp3(+) Regulatory T Cells Maintain a Normal Phenotype and Suppress Immune-Mediated Ocular Surface Inflammation54345440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=777]], camposKey:1043-4666 2008-01-01 Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation160167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=666]], camposKey:1744-666X 2008-01-01 Cytokines and chemokines in immune-based ocular surface inflammation457467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3553]], camposKey:0365-6691 2008-01-01 Limbal transplantation: Multicenter retrospective case series analysis Estudio multicéntrico retrospectivo sobre trasplante de limbo417422, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=677]], camposKey:1528-4050 2007-10-01 Clinical grading of atopic keratoconjunctivitis442445, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11096]], camposKey:0098-8243 2007-06-01 Conjunctival pigmentation in Stevens-Johnson syndrome99103, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=787]], camposKey:0105-4538 2007-06-01 Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report683694, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=705]], camposKey:1530-4086 2007-03-01 Conjunctival pigmentation in Stevens-Johnson syndrome152157, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=668]], camposKey:0179-1958 2007-03-01 Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis333334, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=764]], camposKey:0146-0404 2007-01-01 Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye40264032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29868]], camposKey:0212-4394 2007-01-01 Líneas de investigación del Grupo de Superficie Ocular del IOBA218220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3554]], camposKey:1542-0124 2007-01-01 Methodologies to diagnose and monitor dry eye disease: Report of the diagnostic methodology subcommittee of the international Dry Eye Workshop (2007)108152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=716]], camposKey:0142-9612 2007-01-01 Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)15531564, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29869]], camposKey:0212-4394 2007-01-01 Sensibilidad corneal: una medida clave para la salud ocular618626, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=656]], camposKey:1462-0324 2006-12-01 Severe keratopathy in paediatric Cogan's syndrome15761577, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=771]], camposKey:0003-9950 2006-01-01 Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis462468, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=767]], camposKey:0146-0404 2006-01-01 Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance14161425, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=665]], camposKey:1528-4050 2006-01-01 Muscarinic receptors in the ocular surface379382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41614]], camposKey:1560-2133 2005-07-21 Dry eye disease: Current therapies and related systemic diseases1215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=649]], camposKey:1058-4838 2005-03-01 Cat-scratch disease (ocular bartonellosis) presenting as bilateral recurrent iridocyclitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=765]], camposKey:0021-9541 2005-03-01 OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane929935, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=750]], camposKey:0271-3683 2005-01-01 Alpha(2)-Adrenergic receptors are present in normal human conjunctiva11211129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56142]], camposKey:0146-0404 2005-01-01 Can ocular mucin gene levels be used as an Investigational diagnostic test for dry eye?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74101]], camposKey:0146-0404 2005-01-01 Development of a biopolymer-epithelium complex for ocular surface reconstruction00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41613]], camposKey:1542-0124 2005-01-01 Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease161164, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=754]], camposKey:0146-0404 2005-01-01 Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium504513, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71399]], camposKey:0146-0404 2005-01-01 Hydrogel contact lens (HCL) wear in controlled adverse environment (CAE) conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56649]], camposKey:0146-0404 2005-01-01 Inflammatory cytokine effects on co-stimulatory molecule and chemokine expression in the human conjunctival epithelial cell line, IOBA-NHC00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71398]], camposKey:0146-0404 2005-01-01 Limbal transplantation in ocular surface disease: Multicenter retrospective case series analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56650]], camposKey:0146-0404 2005-01-01 Ocular surface in vivo tolerance to new nanoparticulate polymer systems designed for drug delivery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=641]], camposKey:1542-0124 2005-01-01 Pathways of corneal and ocular surface inflammation: A perspective from the Cullen Symposium131138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=712]], camposKey:1528-4050 2005-01-01 The role of the conjunctival epithelium in ocular allergy441445, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39488]], camposKey:1542-0124 2005-01-01 Variation in the expression of inflammatory markers and neuroreceptors in human conjunctival epithelial cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=660]], camposKey:0002-9394 2004-12-01 Macular edema as the only ocular finding of tuberculosis10481049, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3559]], camposKey:0365-6691 2004-12-01 Ocular Behçet disease. Retrospective study Enfermedad de Behçet ocular. Estudio retrospectivo.599603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56651]], camposKey:0146-0404 2004-04-01 Presence of alpha 2-adrenergic receptor subtypes in the normal human conjunctiva.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=749]], camposKey:0146-0404 2004-01-01 Comparison of antioxidant enzymes genes expression changes in conjunctival epithelium induced by non ionic hydrogel contact lenses with different oxigen permeability.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=748]], camposKey:0146-0404 2004-01-01 Comparison of mucin genes expression alterations in conjunctival epithelium induced by high and low water content hydrogel contact lenses.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=782]], camposKey:0146-0404 2004-01-01 Corneal thickness changes after one year of hydrogel contact lens00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=778]], camposKey:0014-4835 2004-01-01 Impression cytology of the ocular surface: a review457472, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13959]], camposKey:0365-6691 2004-01-01 Oftalmía simpática postvitrectomía tras traumatismo y taponamiento con perfluorocarbono líquido553556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49629]], camposKey:0365-6691 2004-01-01 Sympathetic ophthalmia post-vitrectomy following trauma and perfluorocarbon liquid tamponade Oftalmía simpática postvitrectomía tras traumatismo y taponamiento con perfluorocarbono líquido.553556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=645]], camposKey:1529-7322 2003-07-01 Animal models of ocular allergy and their clinical correlations345351, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55936]], camposKey:0146-0404 2003-05-01 Antioxidant enzyme genes expression in conjunctival epithelium of normal subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56666]], camposKey:0146-0404 2003-05-01 Effect of IFN gamma on muscarinic and adrenergic receptor expression in a normal human conjunctival (NHC) epithelial cell line: Flow cytometry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56668]], camposKey:0146-0404 2003-05-01 Expression of neurotransmitter receptors and Vip in conjunctival biopsies of vernal keratoconjunctivitis patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56664]], camposKey:0146-0404 2003-05-01 In vitro models of ocular inflammation using normal human conjunctival cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56667]], camposKey:0146-0404 2003-05-01 Western blot analysis of muscarinic and adrenergic receptors in a normal human conjunctival (NHC) epithelial cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=737]], camposKey:0146-0404 2003-01-01 Alteration of conjunctival mucin gene expression in tear-deficient Dry Eye Syndrome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53793]], camposKey:0146-0404 2003-01-01 Antioxidant Enzyme Genes Expression in Conjunctival Epithelium of Normal Subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49633]], camposKey:0365-6691 2003-01-01 Can the use of intraocular silicone oil increase the risk of sympathetic ophthalmia? ¿Puede aumentar el riesgo de oftalmía simpática el uso intraocular de aceite de silicona?3942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=758]], camposKey:0146-0404 2003-01-01 Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva42634274, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=745]], camposKey:0146-0404 2003-01-01 Comparison of central corneal thickness measured with ultrasonic pachometer, Orbscan (R) and OCT (R)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=687]], camposKey:0277-3740 2003-01-01 Human epithelium from conjunctival impression cytology expresses MUC7 mucin gene665671, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=781]], camposKey:0146-0404 2003-01-01 Levels of antioxidant enzyme genes in conjunctival impression cytology specimens from hydrogel contact lenses wearers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=723]], camposKey:0271-3683 2003-01-01 Levels of mucin gene expression in normal human conjunctival epithelium in vivo323328, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=770]], camposKey:0146-0404 2003-01-01 Low water content hydrogel contact lenses (HCL) induce corneal irregularity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3560]], camposKey:0365-6691 2003-01-01 Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes Expresión de los genes de mucinas MUC13, MUC15, MUC16 y MUC17 en el epitelio conjuntival normal humano in vivo.375381, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=775]], camposKey:0146-0404 2003-01-01 Prospective variation in the expression of the conjunctival mucin genes Muc5ac, Muc7, Muc16, and Muc17 before, during and after contact lens wear00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13969]], camposKey:0365-6691 2003-01-01 ¿Puede aumentar el riesgo de oftalmía simpática el uso intraocular de aceite de silicona?3942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=28754]], camposKey:0365-6691 2003-01-01 Síntomas y signos de ojo seco en usuarios de lentes de contacto hidrofílicas: relación con el hábito de fumar543547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56665]], camposKey:0146-0404 2002-05-01 Immunodetection of muscarinic and adrenergic receptors in an epithelial cell line from human conjunctiva00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=762]], camposKey:0146-0404 2002-01-01 Characterization of an epithelial cell line derived from normal human conjunctiva (NHC cell line)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=756]], camposKey:0146-0404 2002-01-01 Comparison of ocular surface alterations induced by high and low water content hydrogel contact lenses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=744]], camposKey:0146-0404 2002-01-01 Cyclosporin A does not alter the expression of ocular mucin genes in a normal human conjunctival (NHC) cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=710]], camposKey:0271-3683 2002-01-01 Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats3945, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=740]], camposKey:0065-2598 2002-01-01 Human conjunctival epithelium in culture: A tool to assay new therapeutic strategies for dry eye307311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42335]], camposKey:0365-6691 2002-01-01 Ocular sarcoidosis. Retrospective study of 18 cases Sarcoidosis ocular. Estudio retrospectivo de 18 casos.301308, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=733]], camposKey:0146-0404 2002-01-01 Range of mucin gene expression in normal human conjunctival epithelium in vivo00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=785]], camposKey:1046-6673 2001-09-01 Creatine transport in brush-border membrane vesicles isolated from rat kidney cortex18191825, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=678]], camposKey:0927-3948 2001-09-01 Fuchs' heterochromic iridocyclitis: A review of 26 cases169175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54147]], camposKey:0146-0404 2001-03-15 Is silicone oil intraocularly injected related to a higher prevalence of sympathetic ophthalmia?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71400]], camposKey:0146-0404 2001-03-15 Modified staining protocol enables light microscopy evaluation of conjunctival impression cytology samples collected by polyethersulfone (PES) filter paper.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71401]], camposKey:0146-0404 2001-03-15 Ocular mucin gene expression in conjunctival impression cytology samples from healthy donors.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=654]], camposKey:0039-6257 2001-03-01 The treatment of dry eye00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=793]], camposKey:0031-6768 2001-02-01 A Na+-dependent D-mannose transporter in the apical membrane of chicken small intestine epithelial cells686691, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3564]], camposKey:0365-6691 2001-01-01 Acute macular neuroretinopathy: a case report Neuro-retinopatía macular aguda: a propósito de un caso.319322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3563]], camposKey:0365-6691 2001-01-01 In vitro toxicity of non-preserved artificial-tear formulations Lágrimas artificiales sin conservantes: estudio comparativo in vitro.613619, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=726]], camposKey:0927-3948 2001-01-01 Pars planitis: epidemiology, treatment, and association with multiple sclerosis93102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3565]], camposKey:0365-6691 2001-01-01 Usefulness of conjunctival biopsy as diagnostic technique Utilidad de la biopsia conjuntival como técnica diagnóstica.3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=62600]], camposKey:0365-6691 2001-01-01 Usefulness of conjunctival biopsy as diagnostic technique
Utilidad de la biopsia conjuntival como técnica diagnóstica3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71257]], camposKey:0146-0404 2000-03-15 Pars planitis: Epidemiology, treatment, visual outcome and association with multiple sclerosis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41615]], camposKey:1395-3931 2000-01-01 Ocular allergies: Association with immune dermatitis6975, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71402]], camposKey:0146-0404 1999-03-15 Human epithelial conjunctival primary cultures grown on a biological support00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41616]], camposKey:1395-3931 1999-01-01 Classification of ocular atopic/allergic disorders and conditions: An unsolved problem1013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=724]], camposKey:0271-3683 1999-01-01 Ultrastructural evidence of mucus I human conjunctival epithelial cultures95105, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=721]], camposKey:0277-3740 1998-07-01 Carbomer- versus cellulose-based artificial-tear formulations: Morphologic and toxicologic effects on a corneal cell line433440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42606]], camposKey:0365-6691 1998-01-01 Análisis retrospectivo de la eficacia de la cirugía en pacientes con uveítis367374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=774]], camposKey:0277-3740 1998-01-01 Analysis of human ocular mucus: Effects of neuraminidase and chitinase enzymes200207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=734]], camposKey:0271-3683 1998-01-01 Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat3946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=741]], camposKey:1080-7683 1998-01-01 Expression of ICAM-1 and HLA-DR by human conjunctival epithelial cultured cells and modulation by nedocromil sodium517531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42607]], camposKey:0365-6691 1998-01-01 Queratitis inducida por el abuso de anestésicos tópicos: caso clínico5759, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41436]], camposKey:0146-0404 1997-12-01 Evaluation of chitosan as a substitute for the mucus layer of the preocular tear film00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=720]], camposKey:0721-832X 1997-05-01 Characterization of epithelial primary cultures from human conjunctiva268276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71293]], camposKey:0146-0404 1997-03-15 Evaluation of chitosan as a substitute for the mucus layer of the preocular tear film646646, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71291]], camposKey:0146-0404 1997-03-15 Evidence of mucin production in cultured conjunctival epithelium757757, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42614]], camposKey:0365-6691 1997-01-01 Alteraciones corneales y palpebrales en el síndrome de hiperlaxitud palpebral445452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3570]], camposKey:0365-6691 1997-01-01 Diagnostic tests of blepharitis-associated dry-eye syndrome. Usefulness of topical anesthesia Test diagnosticos del sindrome de ojo seco asociado a blefaritis, utilidad de la anestesia topica437444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42610]], camposKey:0365-6691 1997-01-01 Distribución de las uveítis en un centro de referencia665670, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41434]], camposKey:0146-0404 1997-01-01 Evidence of mucin production in cultured conjunctival epithelium00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=735]], camposKey:0146-0404 1997-01-01 In vitro study on the toxic effects of carbomer-derived versus carboxymethylcellulose (CMC)-derived artificial tear formulations upon corneal cells749749, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=667]], camposKey:0927-3948 1997-01-01 Influence of topical anesthesia on tests diagnostic of blepharitis-associated dry eye syndrome3342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55200]], camposKey:0365-6691 1997-01-01 Test diagnósticos del síndrome de ojo seco asociado a blefaritis: utilidad de la anestesia tópica437444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42611]], camposKey:0365-6691 1997-01-01 Tinción diferencial mediante lectinas de la capa mucosa de la película lagrimal precorneal y hongos en un modelo animal de queratitis micótica1116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=698]], camposKey:0003-9950 1996-05-01 Referral patterns of uveitis in a tertiary eye care center593599, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71302]], camposKey:0146-0404 1996-02-15 Corneal incorporation of exogenous hyaluronic acid on a lamellar keratectomy animal model25342534, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71307]], camposKey:0146-0404 1996-02-15 Nedocromil sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro226226, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41617]], camposKey:0146-0404 1996-01-01 Corneal incorporation of exogenous hyaluronic acid on a lamellar keratectomy animal model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=709]], camposKey:1081-1206 1996-01-01 Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy124130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3573]], camposKey:0724-8741 1996-01-01 Erratum: Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A (Pharmaceutical Research, 13(2), 311-315, (1996))14230, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41437]], camposKey:0146-0404 1996-01-01 Nedocromil Sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=700]], camposKey:0927-3948 1996-01-01 Phlyctenular keratoconjunctivitis - A potentially blinding disorder119123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=634]], camposKey:0724-8741 1996-01-01 Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A311315, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71310]], camposKey:0146-0404 1995-03-15 CAN CONJUNCTIVAL EPITHELIAL-CELLS WORK AS ANTIGEN-PRESENTING CELLS (APCS)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39500]], camposKey:0146-0404 1995-03-15 CHARACTERIZATION OF HUMAN CONJUNCTIVAL EPITHELIAL-CELLS IN CULTURE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71308]], camposKey:0146-0404 1995-03-15 DIFFERENTIAL STAINING OF MUCUS AND FUNGI IN AN ANIMAL-MODEL OF MYCOTIC KERATITIS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71309]], camposKey:0146-0404 1995-03-15 PRESENCE OF MUCUS ON CULTURED CONJUNCTIVAL EPITHELIAL-CELLS TREATED WITH HYDROCORTISONE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71397]], camposKey:0277-3740 1995-01-01 CALCAREOUS CORNEAL DEGENERATION - REPORT OF 2 CASES97102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41618]], camposKey:0277-3740 1995-01-01 Calcareous corneal degeneration: Report of two cases97102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=761]], camposKey:0146-0404 1995-01-01 Effect of the enzymes chitinase and neuraminidase on the structure of human ocular mucus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=643]], camposKey:0271-3683 1995-01-01 Experimental model of allergic conjunctivitis to ragweed in guinea pig487494, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=658]], camposKey:0146-0404 1995-01-01 OCULAR PENETRATION OF 1-PERCENT CYCLOSPORINE (CYA) FROM NANOCAPSULES AND CONVENTIONAL FORMATIONS IN RABBIT EYES00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40666]], camposKey:0146-0404 1995-01-01 TOPICAL APPLICATION OF NANOCAPSULES OF CYCLOSPORINE-A (CYA) ON A PENETRATING KERATOPLASTY REJECTION MODEL00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71319]], camposKey:0146-0404 1994-03-15 APHAKIC PSEUDOPHAKIC CORNEAL EDEMA (A/PCE) - HISTOPATHOLOGIC STUDY17841784, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=776]], camposKey:0146-0404 1994-01-01 Chromatographic purification of human ocular mucus and structural-analysis by enzymatic means17951795, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3574]], camposKey:0365-6691 1994-01-01 Comparative clinical trial of 2% hydroxypropyl-methylcellulose versus 1% sodium hyaluronate in extracapsular surgery ESTUDIO CLINICO COMPARATIVO DE LA HIDROXIPROPIL-METILCELULOSA 2% QUIRURGICA VERSUS HIALURONATO SODICO 1% EN LA CIRUGIA EXTRACAPSULAR DE CATARATA39, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43850]], camposKey:0365-6691 1994-01-01 Estudio clínico-comparativo de la hidroxipropil-metilcelulosa 2% quirúrgica versus hialuronato sódico 1% en la cirugía extracapsular de catarata310, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42620]], camposKey:0365-6691 1994-01-01 Factores clínicos que predisponen al fracaso de transplante de cornea: rechazo inmune659666, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42609]], camposKey:0365-6691 1994-01-01 Queratoplastia en el edema de córnea del afáquico: correlación clínico-patológica311318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=747]], camposKey:0146-0404 1994-01-01 Sensitivity of human uveal melanoma cell-lines to the type-2 ribosome-inactivating proteins (rips) ricin, ebulin-1, and nigrin-b19271927, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71326]], camposKey:0146-0404 1993-03-15 COMPARISON OF THE SENSITIVITY AND SPECIFICITY OF DIAGNOSTIC-TESTS WITH AND WITHOUT TOPICAL ANESTHESIA FOR DRY EYE SYNDROME IN BLEPHARITIS919919, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71328]], camposKey:0146-0404 1993-03-15 EFFICACY OF 2-PERCENT NEDOCROMIL SODIUM COMPARED TO 2-PERCENT SODIUM CROMOGLYCATE IN A MODEL OF ALLERGIC CONJUNCTIVITIS IN THE GUINEA-PIG844844, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71324]], camposKey:0146-0404 1993-03-15 EPIDEMIOLOGIC RISK-FACTORS PREDISPOSING TO CORNEAL ALLOGRAFT FAILURE10981098, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=707]], camposKey:0161-6420 1993-03-01 SURFACE TOXICITY OF TIMOLOL - REPLY293294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41619]], camposKey:0161-6420 1993-01-01 Authors' reply293294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=795]], camposKey:0021-9258 1993-01-01 Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves.1819518199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=773]], camposKey:0146-0404 1993-01-01 Enzymatic deglycosilation and electrophoretic analysis of the ocular mucus structure14691469, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=794]], camposKey:0167-4412 1993-01-01 Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark ofSambucus nigra L.11811186, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71329]], camposKey:0146-0404 1992-03-15 IMPAIRMENT OF THE OCULAR SURFACE OF THE GUINEA-PIG AFTER LONG-TERM TOPICAL TREATMENT12411241, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=651]], camposKey:0277-3740 1992-01-01 Epidermal Growth Factor and Corneal Wound Healing: A Multicenter Study311314, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42467]], camposKey:0146-0404 1992-01-01 IS CHRONIC APPLICATION OF EYEDROPS RELATED WITH OCULAR ALLERGY850850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=633]], camposKey:0277-3740 1992-01-01 Management of Corneal Complications in Xeroderma Pigmentosum173182, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=690]], camposKey:0161-6420 1992-01-01 Ocular Surface Alteration after Long-term Treatment with an Antiglaucomatous Drug10821088, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=657]], camposKey:0146-0404 1992-01-01 VASCULAR-PERMEABILITY DURING THE EARLY AND LATE PHASES OF OCULAR ANAPHYLAXIS5559, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=692]], camposKey:0146-0404 1991-03-15 ENHANCED OCULAR ANAPHYLAXIS IN THE GUINEA-PIG AFTER LONG-TERM, LOCALLY APPLIED DROPS683683, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=688]], camposKey:0146-0404 1991-03-15 MODIFICATION OF THE OCULAR SURFACE AFTER CHRONIC APPLICATION OF ANTIGLAUCOMATOUS DROPS947947, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55195]], camposKey:0365-6691 1991-01-01 Efecto de la instalación crónica de fármacos sobre la superficie conjuntival8996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3575]], camposKey:0365-6691 1991-01-01 The effect of long-term drug applications on the eye surface8996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=648]], camposKey:0161-6420 1990-01-01 Atopic Keratoconjunctivitis9921000, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41620]], camposKey:1755-375X 1990-01-01 Early and late phases of ocular anaphylaxis in actively immunized guinea pigs470476, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=637]], camposKey:0030-3747 1990-01-01 Effect of Topical Dexamethasone on the Ocular Allergic Reaction in Passively Sensitized Guinea Pigs351358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42616]], camposKey:0365-6691 1990-01-01 Estandarización del estudio de la capa mucoide de la película lagrimal precorneal.453460, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42608]], camposKey:0365-6691 1990-01-01 Evaluación de la anteroposición reglada del oblicuo inferior269274, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=676]], camposKey:0146-0404 1990-01-01 Pharmacologic modulation of vascular permeability in ocular allergy in the rat176180, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69971]], camposKey:0365-6691 1988-01-01 Evaluación de la anteroposición reglada del oblicuo inferior.515518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69931]], camposKey:0365-6691 1988-01-01 Modelo experimental de anafilaxia pasiva conjuntival: Ensayo de fármacos antialérgicos por vía tópica.3344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69970]], camposKey:0365-6691 1987-01-01 Efecto de la cirugía del hilo sobre las endotropías de ángulo variable.719724][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19280]},camposKey: 231 262 Cell Therapy Using Extraocular Mesenchymal Stem Cells 978-3-030-01303-5Corneal Regeneration 1 2019-01-01 Springer, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13804]},camposKey: 129 144 Síndrome de Ojo Seco 978-84-937878-3-7Superficie ocular y biomateriales: lentes de contacto 1 2017-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=112]},camposKey: 101 104 Chitosan-Based Colloidal Systems as Promising Topical Drug Carriers for Ocular Surface Disorders 978-88-7587-431-57th International Symposium on Ocular Pharmacology and Therapeutics 1 2008-01-01 Medimond International Proceedings, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=14830]},camposKey: 89 109 The conjunctiva and tear film maintenance 082474702XDry Eye and Ocular Surface Disorders 1 2004-06-23 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=113]},camposKey: 643 648 Immunosuppressive chemotherapy for non-infectious uveitis 88-323-0601-8SOE '97 1 1997-01-01 Monduzzi Editore, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=111]},camposKey: 33 36 Management of severe atopic keratoconjunctivitis 0444813675Ocular immunology today 1 1990-01-01 -][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=109076],camposKey=84-7762-099-7Anafilaxia conjuntival: desarrollo de un modelo experimental 1 1990-01-01 }][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63542]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64738]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63261]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62189]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62400]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62464]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63848]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63421]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63810]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63369]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64100]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63542]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64738]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63261]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62189]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62400]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62464]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63848]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63421]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63810]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63369]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64100]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31022]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30689]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638396]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638267]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638314]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636906]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636896]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636897]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636892]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631907]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145635412]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631228]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=69871]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624855]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627396]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626757]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626882]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5127d5c1, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@69c12454, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3f950736, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@50a4983d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3fc2d635, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5fc1b61d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@487ab664][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5fc779, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5e0ebe, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3fdab2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9372, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@382d27, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d8828, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375252, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a51, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3ddf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373343, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d71eb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d71ec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3739e2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373427, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37395c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37326d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b7d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ca3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ca2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372be2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372b4d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372be1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372619, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372d65, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37309a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@371f7d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372d66, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37300c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b92, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ae7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3730bf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d76, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d5a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a02, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373be0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d78, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b9f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d0c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3730d4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372acc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d8f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ca0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372fe6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734d4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734f7][][][][][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1370]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1464]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1167]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1166]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1165]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c28], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4689b1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414e9e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@462669], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@466ff6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f841], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41333e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4133af], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412fcd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412570], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f6e1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412577], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f6e0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412448], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125d6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413bdc], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f7c7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412123], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122bc], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460721], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f50], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460600], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411db1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4120e4], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460477], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411ead], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411c9f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411c63], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f46f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412758], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412757], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f375], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41384e]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@156ac, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1409c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14081, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142e1, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14802, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1480c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142a4][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=31171]},camposKey: 90 0 Realización de ensayos clínicos bajo condiciones ambientales controladas en el ¿Controlled Environment Laboratory¿ (CELab) 8412292766La madre de los aires 1 2021-01-01 Fundación 3CIN , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30591]},camposKey: 29 42 Biomarcadores de ojo seco en estudios clínicos 9788412227215Lentes de contacto y superficie ocular: biomateriales 1 2020-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30592]},camposKey: 43 54 Superficie ocular, lentes de contacto y condiciones ambientales 9788412227215Lentes de contacto y superficie ocular: biomateriales 1 2020-01-01 Ulleye]
